https://scholars.lib.ntu.edu.tw/handle/123456789/635104
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Chen, Jung-Yueh | en_US |
dc.contributor.author | SHENG-KAI LIANG | en_US |
dc.contributor.author | Chuang, Tzu-Yi | en_US |
dc.contributor.author | CHIA-YU CHU | en_US |
dc.contributor.author | CHIA-HUNG TU | en_US |
dc.contributor.author | Yeh, Yu-Jo | en_US |
dc.contributor.author | Wei, Yu-Feng | en_US |
dc.contributor.author | KUAN-YU CHEN | en_US |
dc.date.accessioned | 2023-09-05T08:18:27Z | - |
dc.date.available | 2023-09-05T08:18:27Z | - |
dc.date.issued | 2024 | - |
dc.identifier.issn | 0929-6646 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/635104 | - |
dc.description.abstract | Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are used as the standard first-line treatment for patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC). However, the impact of comorbidities and treatment toxicities on quality of life (QoL) was seldom investigated. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Journal of the Formosan Medical Association = Taiwan yi zhi | en_US |
dc.subject | Adverse events; Comorbidity; Epidermal growth factor receptor tyrosine kinase inhibitor; Neutrophil-to-lymphocyte ratio; Non-small cell lung cancer; Quality of life | en_US |
dc.title | The impact of comorbidities, neutrophil-to-lymphocyte ratio, and drug toxicities on quality of life in lung cancer patients receiving EGFR-TKI therapy | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1016/j.jfma.2023.07.017 | - |
dc.identifier.pmid | 37563020 | - |
dc.identifier.scopus | 2-s2.0-85167561708 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85167561708 | - |
dc.relation.pages | 198 | en_US |
dc.relation.journalvolume | 123 | en_US |
dc.relation.journalissue | 2 | en_US |
dc.relation.pageend | 207 | en_US |
item.fulltext | no fulltext | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.cerifentitytype | Publications | - |
item.openairetype | journal article | - |
item.grantfulltext | none | - |
crisitem.author.dept | Medicine-NTUCC | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUHHC | - |
crisitem.author.dept | Dermatology | - |
crisitem.author.dept | Dermatology-NTUH | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.orcid | 0000-0003-3486-2293 | - |
crisitem.author.orcid | 0000-0002-9370-3279 | - |
crisitem.author.orcid | 0000-0002-5723-5893 | - |
crisitem.author.orcid | 0000-0002-5639-9773 | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | NTU Hsin-Chu Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學院附設癌醫中心醫院(臺大癌醫) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。